Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRNB

Principia Biopharma (PRNB) Stock Price, News & Analysis

Principia Biopharma logo

About Principia Biopharma Stock (NASDAQ:PRNB)

Advanced Chart

Key Stats

Today's Range
$100.05
$100.05
50-Day Range
$99.95
$100.27
52-Week Range
$25.35
$101.89
Volume
N/A
Average Volume
729,676 shs
Market Capitalization
$3.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Principia Biopharma and its competitors with MarketBeat's FREE daily newsletter.

PRNB Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Principia College names new president
See More Headlines

PRNB Stock Analysis - Frequently Asked Questions

Principia Biopharma Inc. (NASDAQ:PRNB) posted its earnings results on Thursday, August, 6th. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of ($1.03) by $1.34. The business had revenue of $50 million for the quarter, compared to analysts' expectations of $50 million.

Principia Biopharma (PRNB) raised $75 million in an IPO on Friday, September 14th 2018. The company issued 4,700,000 shares at $15.00-$17.00 per share. BofA Merrill Lynch, Leerink Partners and Wells Fargo Securities acted as the underwriters for the IPO and Baird was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Principia Biopharma investors own include Pfizer (PFE), Advanced Micro Devices (AMD), AbbVie (ABBV), Bristol Myers Squibb (BMY), Cisco Systems (CSCO), QUALCOMM (QCOM) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
8/06/2020
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PRNB
CIK
N/A
Fax
N/A
Employees
65
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-23.08%
Return on Assets
-21.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.01
Quick Ratio
17.01

Sales & Book Value

Annual Sales
$35.16 million
Price / Sales
94.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.95 per share
Price / Book
9.14

Miscellaneous

Outstanding Shares
33,209,000
Free Float
N/A
Market Cap
$3.32 billion
Optionable
Not Optionable
Beta
0.86
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:PRNB) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners